Abstract
Background
The purpose of this study was to evaluate the efficacy and safety of implementation of telemedicine and the Thammasat Stroke Network model in treating acute ischemic stroke patients with intravenous thrombolysis.
Methods
Telemedicine (telephone consultation and tele-radiology) has been used in acute ischemic stroke management since June, 2007. The Thammasat Stroke Network (TSN) was effectively organized in March, 2008. Thammasat Hospital served as a “hub” hospital, with 25 “spoke” hospitals in the TSN. The main outcome measures included favorable outcome of the patients treated with intravenous tissue plasminogen activator (tPA) at 3 months and symptomatic intracerebral hemorrhage by comparison between walk-in patients and the patients who were referred by the TSN.
Results
There were 14 patients (14 out of 170 acute ischemic stroke patients, 8%) and 110 patients (110 out of 406 patients, 27%) receiving tPA, before and after implementation of TSN, respectively. Walk-in patients (66 patients) had significant shorter onset-to-treatment duration as compared with referred patients (58 patients) (130 vs. 170 min, P < 0.0001). However, there was no significant difference in favorable outcome (48 vs. 42%, P = 0.538) and rate of symptomatic intracerebral hemorrhage (3 vs. 2%, P = 0.637).
Conclusion
Implementation of telemedicine and TSN markedly increased tPA administrations, without compromising favorable and safety outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
de Bustos EM, Vuillier F, Chavot D, Moulin T. Telemedicine in stroke: organizing a network-rationale and baseline principles. Cerebrovasc Dis. 2009;27(suppl 4):1–8.
Schwamm LH, Halloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616–34.
Dharmasaroja P. Baseline characteristics of patients with acute ischemic stroke in a suburban area of Thailand. J Stroke Cerebrovasc Dis. 2008;17(2):82–5.
Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: the first prospective evaluation. Clin Neurol Neurosurg. 2006;108:549–52.
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581–1587.
Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of the thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet. 1998;352:1245–51.
Wu O, Langhorne P. The challenge of acute stroke management: does telemedicine offer a solution? Int J Stroke. 2006;1:201–7.
LaMonte MP, Bahouth MN, Hu P, et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke. 2003;34:725–8.
Wang S, Gross H, Lee SB, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke. 2004;35:1763–8.
Hess DC, Wang S, Hamilton W, et al. REACH: clinical feasibility of a rural telestroke network. Stroke. 2005;36:2018–20.
Audebert HJ, Kukla C, Vatankhan B, et al. Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke. 2006;37:1822–7.
Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol. 2006;5:742–8.
Schwab S, Vatakhan B, Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology. 2007;69:898–903.
Ickenstein GW, Horn M, Schenkel J, et al. The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities. Neurocrit Care. 2005;3:27–32.
Audebert HJ, Kukla C, von Claranau SC, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke. 2005;36:287–91.
Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomized, blinded, prospective study. Lancet Neurol. 2008;7:787–95.
Vaishnav AG, Pettigrew LC, Ryan S. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals. Clin Neurol Neurosurg. 2008;110:451–4.
Acknowledgments
This research is funded by Faculty of Medicine, Thammasat University. Thanks to Mrs. Valerie Webb Suwanseree for help in editing the manuscript.
Conflicts of interest statement
We have no conflicts of interest/disclosures
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dharmasaroja, P.A., Muengtaweepongsa, S. & Kommarkg, U. Implementation of Telemedicine and Stroke Network in Thrombolytic Administration: Comparison Between Walk-in and Referred Patients. Neurocrit Care 13, 62–66 (2010). https://doi.org/10.1007/s12028-010-9360-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-010-9360-3